Evaluation and staging of squamous cell carcinoma of the oral cavity and oropharynx. Limitations despite technological breakthroughs

Otolaryngologic Clinics of North America

Volumn 46, Issue 4, 2013, Pages 599-613

  Zafereo, Mark E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Diagnosis; Evaluation; Human papillomavirus; PET; Prognosis; Sentinel lymph node biopsy; Smoking; Squamous cell carcinoma oral cavity; Squamous cell carcinoma oropharynx; Staging

Indexed keywords

CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; MOUTH SQUAMOUS CELL CARCINOMA; OROPHARYNX SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SMOKING; SQUAMOUS CELL CARCINOMA; WART VIRUS;

DIAGNOSIS; EVALUATION; HUMAN PAPILLOMAVIRUS; PET; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SMOKING; SQUAMOUS CELL CARCINOMA ORAL CAVITY; SQUAMOUS CELL CARCINOMA OROPHARYNX; STAGING;

CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY;

EID: 84881023472     PISSN: 00306665     EISSN: 15578259     Source Type: Journal    
DOI: 10.1016/j.otc.2013.04.011     Document Type: Review

References (65)

1. Liang X.H., Lewis J., Foote R., et al. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. JOral Maxillofac Surg 2008, 66:1875-1880.
2. Ha P.K., Pai S.I., Westra W.H., et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 2002, 8(5):1203-1209.
3. Cancer of the head and neck. Cancer of the oral cavity. Myers EN, Simental AA 2003, 289-290. Elsevier, Philadelphia. E.N. Myers, J.Y. Suen, J.N. Myers (Eds.).
4. Attner P., Du J., Nasman A., et al. The role of human papilloma virus (HPV) in the increased incidence of base of tongue cancer. Int J Cancer 2010, 126(12):2879-2884.
5. Nasman A., Attner P., Hammarstedt L., et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer 2009, 125:362-366.
6. Dahlstrom K.R., Calzada G., Hanby J.D., et al. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer 2012, 10.1002/cncr.27727.
7. Ang K.K., Harris J., Wheeler R., et al. Human papillomavirus (HPV) and survival of patients with oropharyngeal cancer. NEngl J Med 2010, 363:24-35.
8. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. JNatl Cancer Inst 2008, 100:261-269.
9. Ang K.K., Sturgis E.M. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol 2012, 22:128-142.
10. Corey A.S., Hudgins P.A. Radiographic imaging of human papillomavirus related carcinomas of the oropharynx. Head Neck Pathol 2012, 6:S25-S40.
11. Goldenberg D., Begum S., Westra W.H., et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008, 30(7):898-903.
12. Westra W.H. Detection of human papillomavirus in clinical samples. Otolaryngol Clin North Am 2012, 45:765-777.
13. El-Naggar A.K., Westra W.H. p16 Expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck 2012, 34(4):459-461.
14. AJCC cancer staging manual 2010, Springer Science and Business Media, Available at:, Accessed September 16, 2012. http://www.springer.com, 7th edition.
15. Kreppel M., Eich H.T., Kubler A., et al. Prognostic value of the sixth edition of the UICC's TNM classification and stage grouping for oral cancer. JSurg Oncol 2010, 102:443-449.
16. Huang S.H., Hwang D., Lockwood G., et al. Predictive value of tumor thickness for cervical lymph node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer 2009, 115(7):1489-1497.
17. Sparano A., Weinstein G., Chalian A., et al. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 2004, 131:472-476.
18. Brandwein-Gensler M., Teixeira M.S., Lewis C.M., et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005, 29:167-178.
19. Binmadi N.O., Basile J.R. Perineural invasion in oral squamous cell carcinoma: a discussion of significance and review of the literature. Oral Oncol 2011, 47:1005-1010.
20. Woolgar J.A. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2006, 42:229-239.
21. Woolgar J.A., Scott J. Prediction of cervical lymph node metastasis in squamous cell carcinoma of the tongue/floor of mouth. Head Neck 1995, 17:463-472.
22. Fan K.H., Wang H.M., Kang C.J., et al. Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates. Int J Radiat Oncol Biol Phys 2010, 77(4):1024-1029.
23. Johnson J.T., Myers E.N., Bedetti C., et al. Cervical lymph node metastasis. Arch Otolaryngol 1985, 11:534-537.
24. Cherncok R.D., Zhang Q., El-Mofty S.K., et al. Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. Arch Otolaryngol Head Neck Surg 2011, 137(2):163-169.
25. Chaturvedi A.K., Engels E.A., Anderson W.F., et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. JClin Oncol 2008, 26:612-619.
26. Rischin D., Young R.J., Fisher R., et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. JClin Oncol 2010, 28:4142-4148.
27. Lassen P., Eriksen J.G., Krogdahl A., et al. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6 and 7 trial. Radiother Oncol 2011, 100:49-55.
28. Posner M.R., Lorch J.H., Goloubeva O., et al. Survival and human papillomavirus in oropharynx cancer in tax 324: a subset analysis from an international phase III trial. Ann Oncol 2011, 22:1071-1077.
29. Gillison M.L., D'Souza G., Westra W., et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. JNatl Cancer Inst 2008, 100:407-420.
30. D'Souza G., Zhang H.H., D'Souza W.D., et al. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol 2010, 46:100-104.
31. Hafkamp H.C., Manni J.J., Haesevoets A., et al. Marked differences in survival rate between smokers and nonsmokers with HPV16-associated tonsillar carcinomas. Int J Cancer 2008, 122:2656-2664.
32. Kumar B., Cordell K.G., Lee J.S., et al. EGFR, p16, HPV Titer, Bcl-xL, and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. JClin Oncol 2008, 26:3128-3137.
33. Maxwell H., Kumar B., Feng F.Y., et al. Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 2010, 16:1226-1235.
34. Gillison M.L., Zhang Q., Jordan R., et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. JClin Oncol 2012, 30(17):2102-2111.
35. Haughey B.H., Sinha P. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope 2012, 122:S13-S33.
36. Haughey B.H., Hinni M.L., Salassa J.R., et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck 2011, 33:1683-1694.
37. Straetmans J.M., Olthof N., Mooren J.J., et al. Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope 2009, 119:1951-1957.
38. Don D.M., Anzai Y., Lufkin R.B., et al. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope 1995, 105(7):669-674.
39. Gourin C.G., Conger B.T., Porubsky E.S., et al. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma. Laryngoscope 2008, 118(7):1191-1194.
40. Tankere F., Camproux A., Barry B., et al. Prognostic value of lymph node involvement in oral cancers: a study of 137 cases. Laryngoscope 2000, 110:2061-2065.
41. van den Brekel M.W., van der Waal I., Meijer C.J., et al. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 1996, 106:987-991.
42. Pitman K.T., Johnson J.T., Myers E.N. Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolaryngol Head Neck Surg 1997, 123:917-922.
43. Byers R.M., Wolf P.F., Ballantyne A.J. Rationale for elective modified neck dissection. Head Neck Surg 1988, 10:160-167.
44. Alkureishi L.W., Burak Z., Alvarez J.A., et al. Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2009, 16:3190-3210.
45. Stoeckli S.J., Broglie M.A. Sentinel node biopsy for early oral carcinoma. Curr Opin Otolaryngol Head Neck Surg 2012, 20(2):103-108.
46. Broglie M.A., Haile S.R., Stoeckli S.J. Long-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2011, 18(10):2732-2738.
47. Alkureishi L.W., Ross G.L., Shoaib T., et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol 2010, 17:2459-2464.
48. Civantos F.J., Zitsch R.P., Schuller D.E., et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multiinstitutional trial. JClin Oncol 2010, 28:1395-1400.
49. Schiefke F., Akdemir M., Weber A., et al. Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection. Head Neck 2009, 31:503-512.
50. Murer K., Huber G.F., Haile S.R., et al. Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the N0 neck in patients with oral squamous cell carcinoma. Head Neck 2011, 33:1260-1264.
51. Broglie M.A., Haerle S.K., Huber G.F., et al. Occult metastases detected by sentinel node biopsy in patients with early oral and oropharyngeal squamous cell carcinomas: impact on survival. Head Neck 2012, 10.1002/hed.23017.
52. Haerle S.K., Stoeckli S.J. SPECT/CT for lymphatic mapping of sentinel nodes in early squamous cell carcinoma of the oral cavity and oropharynx. Int J Mol Imaging 2011, 106068. Available at:. http://www.hindawi.com/journals/ijmi/2011/106068.
53. Ferris R.L., Xi L., Seethala R.R., et al. Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer. Clin Cancer Res 2011, 17:1858-1866.
54. Vermeeren L., Valdés Olmos R.A., Klop W.M., et al. Aportable gamma-camera for intraoperative detection of sentinel nodes in the head and neck region. JNucl Med 2010, 51(5):700-703.
55. Wendler T., Hartl A., Lasser T., et al. Towards intraoperative 3D nuclear imaging: reconstruction of 3D radioactive distributions using tracked gamma probes. Med Image Comput Comput Assist Interv 2007, 10:909-917.
56. Aderson R.S., Eifert B., Tartt S., et al. Radioimmunoguided surgery using indium-111 capromab pendetide (PROSTASCINT) to diagnose supraclavicular metastasis from prostate cancer. Urology 2000, 56:669.
57. Available at: Accessed September 3, 2012. http://www.clinicaltrials.gov/ct2/show/NCT00911326%3fterm%3dhead+and+neck+cancer+sentinel+lymph+node%26rank%3d5.
58. Cashman E.C., MacMahon P.J., Shelly M.J., et al. Role of positron emission tomography-computed tomography in head and neck cancer. Ann Otol Rhinol Laryngol 2011, 120(9):593-602.
59. Rudmik L., Lau H.Y., Matthews T.W., et al. Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial. Head Neck 2011, 33:935-940.
60. 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol 2007, 18:1698-1703.
61. 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers. Semin Nucl Med 2005, 35:214-219.
62. Hyde N.C., Prvulovich E., Newman L., et al. Anew approach to pretreatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 2003, 39:350-360.
63. Stoeckli S.J., Steinert H., Pfaltz M., et al. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 2002, 24:345-349.
64. Civantos F.J., Gomez C., Duque C., et al. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck 2003, 25:1-9.
65. Xie P., Li M., Zhao H., et al. (18)F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis. JCancer Res Clin Oncol 2011, 137:1085-1093.